1.. Introduction
================

Menopause is defined by permanent cessation of the primary functions of the human ovaries. Hormonal fluctuations that occur during menopause, may affect on the mood and cognitive processes ([@B13]; [@B35]). Emotional disorders such as postpartum and postmenopausal depression are the most common forms of mental illness associated with decreased serum levels of ovarian hormones ([@B51]). Many studies have shown that estrogen deficiency after menopause may impair learning and memory function in women ([@B42]). Moreover, there is a strong relationship between reduced estrogen levels and incidence of Alzheimer's disease (AD) ([@B8]). On the other hand, estrogen replacement therapy is effective for improving or preventing depression and AD, respectively ([@B2]; [@B34]).In fact, it has been shown that estrogen by reduction in β amyloid accumulation and oxidative damage as well as amplification of cerebral blood flow and neurotransmitter release or action, improves brain functions ([@B37]; [@B50]; [@B54]). Nevertheless, the benefits of estrogen replacement therapy in postmenopausal women are usually overshadowed by serious side effects of estrogen ([@B52]). Particularly, the long-term use of estrogen in women may increase the risk of breast and endometrial cancers ([@B7]). Nowadays, there are several propositions for the relief of mood disorders in postmenopausal women, which mainly consists of estrogenic agents, combination therapy and plant-derived natural products ([@B47]). Phytoestrogens and many other estrogen-like compounds in plants, due to fewer side effects, have been massively proposed to prevent menopause-related cognitive decline ([@B24]).

Phytoestrogens are non-steroidal compounds that can behave as estrogen receptor agonist or antagonist ([@B33]). For example, in cell culture, it was observed that these compounds inhibited the growth of estrogen-dependent tumor cells ([@B45]). In contrast, it has been reported that phytoestrogens may have beneficial effects on cognitive performance in postmenopausal women ([@B16]).

Vitex agnus castus (VAC) belongs to the Verbenaceae family and is distributed throughout Mediterranean, Europe, central Asia and the United States ([@B39]).Traditionally, the fruits of this plant have been used as a herbal medicine for treatment of hormone disorders in women so that, the fruit extract is used for the treatment of severe premenstrual syndrome and hot flashes associated with menopause ([@B19]). Its phytoconstituent includes flavonoids, terpenoids and glycosides ([@B6]). It is reported that VAC extract is a proliferation inhibitor and induces apoptosis in prostate epithelial cell lines ([@B53]). In the current study, we used ovariectomized rats as a model of menopause-related estrogen depletion to evaluate the effect of VAC on learning and memory. Moreover, we investigated the effect of VAC extract on uterine weight and estrogen receptor alpha (ERα) gene expression in the hippocampus of the ovariectomized rats.

2.. Methods
===========

2.1.. Animals and treatment
---------------------------

24 female Wistar rats weighted 180--220 g were kept under standard laboratory conditions with a temperature of 20 to 22 °C and maintained on a 12 h light/dark cycle with food and water available adlibitum. Rats were operated through dorsal incision under anesthesia with an intraperitoneal injection of ketamine sulfate solution (60 mg/kg) and xylazine (4 mg/kg). Then, ovaries were removed by a cautery device, wound was closed, and 22,000 i.u/kg penicillin was injected for two days after surgery. Vaginal smears were taken from rats to confirm the absence of ovarian cycles for at least five days ([@B15]).

The animals were randomly divided into four groups (n=6) as following: control (vehicle, saline 1ml/kg); VAC 8 mg/kg; VAC 80 mg/kg and estradiol valerat 40 μg/kg ([@B5]) (Aboureihan Co, Tehran, Iran). All animals were treated daily at 11 A.M. by oral administration (P.O.) of all compounds for three months. The doses of VAC were chosen based on our previous experiments ([@B20]).

2.2.. Extraction of VAC
-----------------------

Vitex agnus castus was purchased from the central herbarium of Isfahan University and was identified by experts of the central herbarium of Isfahan University with registration number 9252, in 2012. The quantities of major components of VAC in Iran have been already reported ([@B14]). The main compositions of the plant's seeds are caryophyllene oxide (25%), n-hexadecane (12.5%), α-terpinyl acetate (11.6%) and bicyclogermacrene (8.4%) ([@B14]). The dried fruit (seeds) of VAC were rinsed with distilled water. After grinding, 500 g of plant was extracted in a Soxhlet apparatus with ethanol. Finally, ethanol was evaporated with a rotary machine and the residual was dried to form a powder. The resultant extract was then reconstituted by solving it in saline before being orally administered to animals.

2.3.. Behavioral testing
------------------------

Step-through passive avoidance (STPA) apparatus was used for the evaluation of learning (Panlab Co, Spain). The apparatus included both light and dark compartments with equal sizes (20 cm×20 cm×30 cm) which were separated by a guillotine door. The floor was made of steel rods with a diameter of 3 mm and 1 cm space. The following experimental protocol was based on the designs described previously ([@B49]). Habitation stage: rats were placed in the laboratory for 30 minutes to habitude to the experimental environment. Animals were transferred to the light compartment and following 5 seconds the guillotine door between the two compartments was removed and the animal was allowed moving freely toward the dark compartment for 5 minute. The animal was removed from the study if it did not enter the dark compartment after 300 seconds. Following entry into the dark side, the guillotine door was closed and the rats were returned to the cage after 10 seconds.Training stage: This stage began 1 h after habituation stage. Each rat was placed in the light compartment following 5 seconds the guillotine door between the two compartments was removed. Following the entrance to the dark compartment, the guillotine door was immediately closed and an electric shock was delivered to the floor bars (0.5 mA, 2s). We repeated the procedure until the latency to enter the dark box was more than 300s. The latency of rat for entering the dark compartment was reported as initial latency (IL).Retention stage: the retention time was measured 24 hours after the training stage. The animals were returned to the light compartment and the latency for entering the dark compartment was reported as Step-through latency (STL). If the rat did not enter the dark compartment during 300 seconds, it was transferred to its cage and 300 seconds was reported (maximum latency) but if the rat entered to the dark compartment, the retention time of rat in the dark compartment was also recorded as total time in dark chamber (TDC) ([@B49]).

2.4.. Locomotor activity test
-----------------------------

Locomotor activity was measured by a glass box with a black plastic floor (35 cm×35 cm×35 cm). Each animal's activity was monitored by a camera during 30 min. The Ethovision software was used to calculate the total distance traveled and average speed (centimeters per second) for each animal ([@B43]).

2.5.. Uterus and brain removal
------------------------------

At the end of behavioral testing, the animals were deeply anesthetized using pentobarbital (80 mg/kg) and then were decapitated by a guillotine. The brains were removed, the hippocampal formations isolated and stored at −80°C until mRNA extraction. The uterine was also removed and weighted in all animals.

2.6.. Real-Time PCR
-------------------

Total mRNA was extracted from hippocampal formation using the RNA extraction kit from Cinnaclon Company (RNX-Solution) (Tehran, Iran). The extracted mRNA quality was identified by measuring absorption at 260/280 nm by a UV spectrophotometer and also using electrophoresis on an ethidium bromide pretreated agarose gel. cDNA was synthesized from extracted mRNA using a cDNA synthesis kit (Parstous, Iran) with oligo (dT) primers. The reverse transcription step was performed using the following steps: 70°C for 10 min (without reverse transcription enzymes), −20°C for 1 min (cooling), addition of reverse transcription enzymes, 42°C for 60 min, following with a final step at 95°C for 10 min. Real-time PCR was performed using a SYBR green master mix (Parstous, Iran), combined with 200 ng of template cDNA with the estrogen receptor alpha (ERα) and Beta-2 microglobulin (B~2~M), as housekeeping gene, primers ([Table 2](#T2){ref-type="table"}) in a Bio-Rad CFX96 system (Bio-Rad Company, USA) using the following program: 1 cycle of 95°C for 15 min, 40 cycles of 95°C for 30 s, and 60°C for 30 s and 72°C for 30 s.

###### 

The effects of long-term administration of Vitex agnus castus ethanolic extract (VAC8 and 80 mg/kg) and estradiol valerat (40 μg/kg) on passive avoidance task in the ovariectomized rats.

                               **Control**   **VAC 80**                                     **VAC 8**                                      **Estradiol valerat**
  ---------------------------- ------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------
  Initial latency              10.1± 1       9.3±1.4                                        9.3±1.3                                        9.7±1
  Step through latency (STL)   28.1±1.6      184.3±31.9[^\*^](#TFN1){ref-type="table-fn"}   178.8±15.2[^\*^](#TFN1){ref-type="table-fn"}   220.8±2.2[^\*^](#TFN1){ref-type="table-fn"}
  Time in dark chamber (TDC)   58.5±4.9      31.1±4.5[^\#^](#TFN2){ref-type="table-fn"}     34.5±2.3[^\#^](#TFN2){ref-type="table-fn"}     24.6±1.7[^\#^](#TFN2){ref-type="table-fn"}
  Shock number                 7.5±0.6       4±0.7[^\$^](#TFN3){ref-type="table-fn"}        5.3±0.4                                        2.6±0.3[^\$^](#TFN3){ref-type="table-fn"}

Significant differences in STL between VAC80, VAC8 and estradiol valerat with control group. All P\<0.001.

Significant differences in TDC between VAC80, VAC8 and estrogen with control group. All P\<0.001.

Significant differences in shock number between VAC80 and estrogen with control group. All P\<0.001. Data expressed as mean±SEM of six animals. Control; group that received saline, VAC80 and VAC8; groups that receive 80 and 8 mg/kg VAC respectively, estrogen; group that received estradiol. All groups were ovariectomized.

Primers were synthesized by the Cinnaclon company (Iran). Real-Time PCR were performed in triplicate and the relative amounts of PCR product were determined by the 2^−ΔΔCt^ formula. The CFX manager software version 1.1.308.111 (Bio-Rad, USA) was used for quantitative analyses of the data and melting curves checking. PCR products were also rechecked by electrophoresis on a 1% gel agarose containing 0.5 mg/ml ethidiumbromide ([@B17]).

2.7.. Statistical analysis:
---------------------------

Data are shown as mean±SEM and analyzed by oneway analysis of variance (ANOVA) and Tukey's test as post-hoc test. In all groups, values were considered statistically significant when P\<0.05.

3.. Results
===========

3.1.. Passive avoidance test
----------------------------

Step-through passive avoidance test was used to assess the memory of animals. ANOVA analysis indicated that oral administration of VAC extract (8 and 80 mg/kg) and estradiol (40 μg/kg) had no significant effect on initial latency (IL) when compared with the control group ([Table 2](#T2){ref-type="table"}) (ANOVA F3=2.009, P\>0.05). The step-through latency (STL) in rats treated with either 8 or 80 mg/kg of VAC extract or estradiol was significantly higher in comparison with control group (F3=23.09, P\<0.001). There was no significant difference between the effects of different doses of VAC on STL (P\>0.05). The effect of VAC on retention latency was also similar to estradiol (P\>0.05) ([Table 1](#T1){ref-type="table"}).

###### 

Primer sequences of evaluated genes.

  **Target gene**                      **Primer sequences**
  ------------------------------------ ----------------------------------
  Estrogen receptor α (ERα)            F: 5′-CAAACCAATGCACCATCGATAA-3′
  R: 5′-TTTTCGTATCCCGCCTTTCA-3′        
  Beta-2 microglobulin (B~2~M)         F: 5′-CCTGGCTCACACTGAATTCACAC-3′
  R: 5′-AACCGGATCTGGAGTTAAACTGGTC-3′   

In line with STL, TDC of rats treated with 8 and 80 mg/ kg extract or estradiol was also decreased significantly in comparison with control group (F3=16.23, all P\<0.001). However, there was no significant difference between different doses of VAC on TDC (P\>0.05). The effect of VAC on TDC was similar to estradiol (F3=16.23, P\>0.05) ([Table 1](#T1){ref-type="table"}). The number of electric shocks needed to reach the criterion (don't enter in dark chamber for at least 300s) (learning phase) of rats treated with estradiol and VAC (80 mg/kg) decreased significantly compared to control group (F3=13.35, all P\<0.001) ([Table 1](#T1){ref-type="table"}).

3.2.. Locomotor activity
------------------------

One-way ANOVA demonstrated that there was no significant difference in locomotor activity of different groups compared with control rats (data not shown).

3.3.. Uterine weight
--------------------

The results revealed a significant increase in the uterine weight in VAC and estradiol treated groups compared to control group (F3=74.97, all P\<0.001) ([Figure 1](#F1){ref-type="fig"}).

![Effects of long-term administration of Vitex agnus castus extract (8 and 80 mg/kg) and estradiol on uterine weight in the ovariectomized rats. ^\*\*\*^ Significant differences among VAC80, VAC8 and estradiol with control group all P\<0.001. Data expressed as mean±SEM of six animals. Control; group that received saline (as vehicle), VAC80 and VAC8; groups that received 80 and 8 mg/kg VAC for three months (p.o.) respectively, estrogen; group that received estradiol for three months (p.o.). All groups were ovariectomized.](BCN-6-185-g001){#F1}

3.4.. mRNA levels of estrogen receptor α in the hippocampal formation
---------------------------------------------------------------------

The results showed that mRNA levels of estrogen receptor α in the hippocampus were increased significantly in VAC80 (F3=11.32, P\<0.05) and estradiol (P\<0.01) groups compared with control group ([Figure 2](#F2){ref-type="fig"}).

![Effects of long-term administration of Vitex agnus castus extract (8 mg/kg and 80 mg/kg) and estradiol on the mRNA levels of α-estrogen receptor in the ovariectomized rats. ^\*^ Significant differences between Vit 80 with control group P\<0.05. ^\*\*^ Significant differences between estradiol with control group P\<0.01.](BCN-6-185-g002){#F2}

4.. Discussion
==============

Our findings indicated that treatment with VAC extract (8 and 80 mg/kg) and estradiol valerat (40 μg/kg) improved learning and memory performance significantly in ovariectomized rats. This improvement of performance in the high dose of VAC was almost equal to estradiol. Furthermore, we observed that VAC extract significantly increased the expression of estrogen receptors α mRNA in hippocampal formation. Our findings also indicated that VAC extract at the dose of 80 mg/kg increased the uterine weight significantly in ovariectomized rats which were similar to estradiol group.

It is well-known that cessation or cyclic fluctuations of ovarian estrogens can influence cognitive functions in woman ([@B12]). In contrast, hormone or phytoestrogen therapy can minimize cognitive changes in postmenopausal women ([@B3]; [@B9]). The role of estrogens in cognitive functions could be explained by the widespread distribution of estrogen receptors in brain regions associated with learning and memory such as hippocampus and basal forebrain (B. S. [@B37]). Hippocampus is a brain area that plays a critical role in cognitive functions ([@B36]) and both ERα and β are expressed in hippo-campus ([@B44]). A number of studies indicated ERα mRNA expression in hippocampal CA1 pyramidal cells both during aging and Alzheimer's disease is lower than normal ([@B21]; [@B22]). Data from animal studies indicated that estradiol therapy can have beneficial effects on cognition through increasing ERα in the hippocampus ([@B4]; [@B40]). In line with this, our results also showed that both estradiol and high dose of VAC increased expression of ERα mRNA in the hippocampal formation.

Phytoestrogens are estrogen-like molecules that have a high affinity for estrogen receptors ([@B25]). Despite their very low affinity for binding to the receptor α, some phytoestrogens such as genistein and quercetin have shown a full agonistic effect for ERα and ERβ in vitro studies ([@B32]). Although the main composition of the plant's fruit has been already detected and reported ([@B14]), in the current study, we focused on whole composition of the extract. Conventional wisdom in traditional medicine suggests that the whole part of a herb, due to synergy of its ingredients, is more effective than its single compositions (S. [@B10]).

Following three months of treatment with VAC extract and estradiol, we have found a significant increase in ERα mRNA expression in the hippocampus, which was in parallel with the findings of other investigators (J. [@B26]). It is well known that extract of VAC contains compounds which bind to ERα and ERβ (J. [@B26]; [@B31]).

Uterus is one of the main target organs for estrogen. Estrogen can increase number of smooth muscle cells, endometrial paranchyme, uterine weight and uterine volume ([@B18]). So it is expected that drugs with estrogen like activity could also increased uterine weight. Our results, similar to previous reports ([@B46]), showed a significant increase in the uterine weight of animals treated with either estradiol or both low and high doses of the plant extract. This can infer more that the VAC has estrogenic effects.

It is proved that synaptic plasticity plays an important role in hippocampal-dependent learning and memory. On the other hand, in the hippocampal neurons, estradiol-induced synaptogenesis is dependent on ER (F. [@B27]). Estradiol-induced synaptogenesis is reported by an increase in synaptic number and synaptic molecular markers ([@B1]; [@B23]). Some studies showed that ERα is the predominate receptor for long-term changes on synaptogenesis ([@B10]). So, it may be possible to suggest that estrogen improved memory function by both increase in ER mRNA expression and neuronal plasticity in the hippocampus ([@B26]; [@B48]). Similarly, it has been reported that phytoestrogens improve learning and memory in ovariectomized rats by increasing synapse density in the hippocampus ([@B27]). Thus, on the basis of our results, we can conclude that oral administration of VAC extract may improve learning and memory in the ovariectomized rats and this effect is comparable with estradiol. The effect of VAC extract in the prevention of learning and memory impairment may be associated with an increase in ERα mRNA in the hippocampal formation. However, low dose of VAC (8mg/kg), in spite of preventing learning and memory impairment, cannot change ERα mRNA expression in hippocampus of ovariectomized rats. This led to conclude that other mechanisms, such as antioxidant ([@B41]), anti-inflammatory (M. M. [@B28]) properties of VAC may be involved in beneficial effects of this plant on learning and memory. So, the exact mechanism of the VAC extract on cognition needs to be further investigated.

In conclusion, result of this study demonstrated that VAC extract improves learning and memory (possibly by a mechanism associated with an increase in ERα gene expression in the hippocampal formation) in ovariectomized rats.
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